Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Apr 16, 2026 3:59:34 PM EDT

14.12USD-1.534%(-0.22)485,989

14.10Bid 14.14Ask 0.04Spread

Pre-market

Apr 16, 2026 8:31:30 AM EDT

14.41USD+0.488%(+0.07)107

After-hours

Apr 16, 2026 4:29:30 PM EDT

14.13USD+0.071%(+0.01)572

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

200.44M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

May 11, 2026 (25d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

458,568

Avg. Vol. 30 Day

460,367

Employees

Market Cap

200,438,208

Shares Out.

14,205,401

On/Off Exchange

51%/49%

6 Month Beta

2.52

1 Year Beta

3.09

2 Year Beta

1.26

3 Year Beta

1.24

52 Week Low

11.60

52 Week High

69.97

SMA50

14.36

SMA200

23.32

1 Week

+8.54%

1 Month

+4.06%

3 Month

-17.68%

6 Month

-24.99%

1 Year

-11.03%

2 Year

-97.06%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $14.12, and today's volume is 485,989. TNXP is down -1.534% today. The 30 day average volume is 460,367. TNXP market cap is 200.44M with 14,205,401 shares outstanding.